4.7 Article

Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Laura E. Stevens et al.

Summary: Inflammatory breast cancer (IBC) is a difficult-to-treat disease with poor clinical outcomes due to high risk of metastasis and resistance to treatment. CD44(+)CD24(-) cells, which possess stem cell-like features, are the most frequent cell type in IBC and are commonly activated by the JAK2/STAT3 signaling pathway. Combination therapy with JAK2/STAT3 inhibition and paclitaxel has shown promising results in decreasing IBC xenograft growth. Furthermore, single-cell analyses have revealed the mechanisms of chemotherapy resistance and the potential of targeting the cAMP/PKA signaling pathway in IBC.

CANCER RESEARCH (2023)

Article Oncology

SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways

Ariana Acevedo-Diaz et al.

Summary: Triple-negative breast cancer (TNBC) is the most aggressive subtype, and this study found that SCAMP3 plays an important role in TNBC development through the regulation of multiple pathways, potentially serving as a target for breast cancer therapy.

CANCERS (2022)

Article Oncology

Characterization of Inflammatory Breast Cancer in Hispanic Women from Puerto Rico

Camiled Quirindongo-Rivera et al.

Summary: This study characterizes the population of Hispanic women with inflammatory breast cancer (IBC) in Puerto Rico and estimates the survival rate of IBC. The results suggest that Puerto Rican IBC patients have unique characteristics, and patients with stage IV disease and ER-/PR- tumor subtype have a higher risk of dying.

JOURNAL OF CANCER (2022)

Review Medicine, Research & Experimental

Metadherin-mediated mechanisms in human malignancies

Yuyuan Chen et al.

Summary: Metadherin (MTDH) is a novel protein critical for the progression of multiple types of human malignancies. It enhances the metastatic potential of cancer cells by regulating multiple signaling pathways and interacts with miRNAs and tumor-related proteins, making it a potential therapeutic target and biomarker. MTDH plays a critical role in inflammation, angiogenesis, hypoxia, epithelial-mesenchymal transition, and autophagy, contributing to cancer initiation and progression.

BIOMARKERS IN MEDICINE (2021)

Review Genetics & Heredity

The Scope of Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH) in Cancer Clinicopathology: A Review

Maheen Khan et al.

Summary: AEG-1 has been established as a crucial oncogene in various types of cancer, playing a significant role in regulating cancer progression through multiple mechanisms. Clinical studies have shown that AEG-1 can serve as an independent biomarker for aggressive and chemoresistant metastatic disease.
Review Medicine, General & Internal

Invasion and Metastasis as a Central Hallmark of Breast Cancer

Trishna Saha et al.

Summary: The hallmarks of cancer introduced by Hanahan and Weinberg are essential biological abilities acquired by human cancer, with invasion and metastasis being key features in breast cancer malignancy. Despite the importance of invasion and metastasis in breast cancer, few clinical trials focus on testing anti-metastasis inhibitors or inhibitors for breast cancer metastasis, presenting obstacles in applying research on invasion and metastasis therapeutics into the clinic.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Oncology

Metadherin: A Therapeutic Target in Multiple Cancers

Gourav Dhiman et al.

FRONTIERS IN ONCOLOGY (2019)

Article Biochemical Research Methods

Primer3_masker: integrating masking of template sequence with primer design software

Triinu Koressaar et al.

BIOINFORMATICS (2018)

Review Oncology

Inflammatory breast cancer biology: the tumour microenvironment is key

Bora Lim et al.

NATURE REVIEWS CANCER (2018)

News Item Oncology

Realistic modeling of tumor cells

Kenneth L. van Golen

ONCOTARGET (2017)

Article Biochemistry & Molecular Biology

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

Wei Wang et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Article Cell Biology

AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation

Jiali Wei et al.

CELL BIOLOGY INTERNATIONAL (2013)

Article Oncology

Modeling and characterization of inflammatory breast cancer emboli grown in vitro

Heather L. Lehman et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Article Biochemical Research Methods

Genome Wide Proteomics of ERBB2 and EGFR and Other Oncogenic Pathways in Inflammatory Breast Cancer

Emma Yue Zhang et al.

JOURNAL OF PROTEOME RESEARCH (2013)

Article Oncology

Inhibition of metadherin sensitizes breast cancer cells to AZD6244

Xiaoli Kong et al.

CANCER BIOLOGY & THERAPY (2012)

Article Biochemistry & Molecular Biology

Primer3-new capabilities and interfaces

Andreas Untergasser et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Oncology

Ganoderma lucidum (Reishi) Inhibits Cancer Cell Growth and Expression of Key Molecules in Inflammatory Breast Cancer

Michelle M. Martinez-Montemayor et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2011)

Review Pharmacology & Pharmacy

Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology

Byoung Kwon Yoo et al.

PHARMACOLOGY & THERAPEUTICS (2011)

Article Oncology

Inflammatory Breast Cancer The Disease, the Biology, the Treatment

Fredika M. Robertson et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2010)

Review Biochemistry & Molecular Biology

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

Sergei I. Grivennikov et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Review Biotechnology & Applied Microbiology

Tight Junctions: A Barrier to the Initiation and Progression of Breast Cancer?

Kieran Brennan et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Biochemistry & Molecular Biology

Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα

E. C. Merkhofer et al.

ONCOGENE (2010)

Article Medicine, Research & Experimental

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression

Byoung Kwon Yoo et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Biotechnology & Applied Microbiology

Gene expression profiling in hepatic tissue of newly weaned pigs fed pharmacological zinc and phytase supplemented diets

Michelle M. Martinez-Montemayor et al.

BMC GENOMICS (2008)

Review Oncology

The epidemiology of inflammatory breast cancer

Paul H. Levine et al.

SEMINARS IN ONCOLOGY (2008)

Article Biochemistry & Molecular Biology

Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling

S-G Lee et al.

ONCOGENE (2008)

Article Biochemistry & Molecular Biology

OligoCalc: an online oligonucleotide properties calculator

Warren A. Kibbe

NUCLEIC ACIDS RESEARCH (2007)

Article Biochemical Research Methods

Enhancements and modifications of primer design program Primer3

Triinu Koressaar et al.

BIOINFORMATICS (2007)

Article Multidisciplinary Sciences

Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

Seok-Geun Lee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Oncology

In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line

Michaela R. Hoffmeyer et al.

CANCER CELL INTERNATIONAL (2005)

Article Pathology

Persistent E-cadherin expression in inflammatory breast cancer

CG Kleer et al.

MODERN PATHOLOGY (2001)